信达生物：2025 年亚洲领袖会议 —— 要点：GLP-1 是减肥的关键手段，目标全球市场

4 September 2025 | 8:51PM HKT Innovent Biologics (1801.HK): Asia Leaders Conference 2025 — Key Takeaways: Glucagon as key moat for mazdutide; Aiming for full global Bottom line: Management shared: 1) glucagon will be the key differentiator for mazdutide to build a competitive moat, 2) three-step plan for IBI363 indication expansion, and 3) aim to build full-chain global capabilities with the first ph3 MRCT as the starting point. Key takeaways: Goldman Sachs does and seeks to do business with companies cover ...